Torrent Pharmaceuticals today said its consolidated net profit declined by 7.28 per cent to Rs 76.91 crore for the third quarter ended December 31, 2010, over the same period previous fiscal.
The Ahmedabad-based company had a consolidated net profit of Rs 82.95 crore in the same period last fiscal.
The company's total income stood at Rs 577.53 crore for the third quarter ended December 31, compared to Rs 480.05 crore in the same period last fiscal, Torrent Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
The company's domestic formulations business reported sales of Rs 214 crore for the third quarter ended December 31, 2010. Its sales outside the country stood at Rs 292 crore.
The company's Brazil sales increased to Rs 102 crore for the third quarter, compared to Rs 89 crore in the same period last fiscal.
The firm's sales in Europe, Russia and CIS and rest of the world operations stood at Rs 78 crore for the third quarter, compared to Rs 64 crore in the same period previous fiscal.
Shares of Torrent Pharmaceuticals today closed at Rs 615.85 on the BSE, up 3.42 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
